scholarly article | Q13442814 |
P2093 | author name string | C G Jackson | |
C L Harris | |||
C Hua | |||
J D Sandy | |||
D O Clegg | |||
A H Plaas | |||
J G Barnhill | |||
S Kim-Rolands | |||
P2860 | cites work | A physiological function of serum proteoglycan bikunin: the chondroitin sulfate moiety plays a central role. | Q35219607 |
Exercise therapy for the management of osteoarthritis of the hip joint: a systematic review | Q37270894 | ||
Determinants of self-reported health status in a population-based sample of persons with radiographic knee osteoarthritis | Q37355326 | ||
Glucosamine/chondroitin/primorine combination therapy for osteoarthritis | Q37409223 | ||
The effects of oral glucosamine on joint health: is a change in research approach needed? | Q37592565 | ||
High-performance liquid chromatography and on-line mass spectrometry detection for the analysis of chondroitin sulfates/hyaluronan disaccharides derivatized with 2-aminoacridone | Q43273475 | ||
Disaccharide composition of hyaluronan and chondroitin/dermatan sulfate. Analysis with fluorophore-assisted carbohydrate electrophoresis | Q43671573 | ||
Efficacy of oxycodone/acetaminophen and codeine/acetaminophen vs. conventional therapy in elderly women with persistent, moderate to severe osteoarthritis-related pain | Q46159393 | ||
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin | Q46403531 | ||
Nutritional supplements for knee osteoarthritis--still no resolution | Q46958310 | ||
Psychological stress impairs Na+-dependent glucose absorption and increases GLUT2 expression in the rat jejunal brush-border membrane | Q48427121 | ||
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers | Q58294663 | ||
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States | Q74552365 | ||
A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee | Q79957127 | ||
Improved and simplified liquid chromatography/electrospray ionization mass spectrometry method for the analysis of underivatized glucosamine in human plasma | Q80419737 | ||
Plasma bikunin as a favorable prognostic factor in ovarian cancer | Q81448533 | ||
Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study | Q22000858 | ||
Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training | Q28254894 | ||
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis | Q33993736 | ||
Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses | Q34383021 | ||
Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose | Q34577442 | ||
Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride | Q34754341 | ||
A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis | Q34911301 | ||
P433 | issue | 3 | |
P921 | main subject | glucosamine | Q32907954 |
pharmacokinetics | Q323936 | ||
P304 | page(s) | 297-302 | |
P577 | publication date | 2009-11-10 | |
P1433 | published in | Osteoarthritis and Cartilage | Q7107605 |
P1476 | title | The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination | |
P478 | volume | 18 |
Q34655436 | Chondroitin and glucosamine in the management of osteoarthritis: an update |
Q36059429 | Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. |
Q38838064 | Chondroitin sulphate: a focus on osteoarthritis |
Q38215383 | Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. |
Q39539742 | Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Plac |
Q87487744 | Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis |
Q24630640 | Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties |
Q37389534 | Current concepts in osteoarthritis |
Q30235140 | Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment |
Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
Q98612959 | Expert Opinion on the Extensive Use of Prescription Crystalline Glucosamine Sulfate in the Multimodal Treatment of Osteoarthritis in Ukraine, Kazakhstan, Uzbekistan, and Armenia |
Q92372433 | Galactosaminoglycans: Medical Applications and Drawbacks |
Q37168084 | Glucosamine activates autophagy in vitro and in vivo |
Q41176136 | Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro |
Q47816389 | Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). |
Q21195259 | Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? |
Q28076979 | Nutraceutical Supplements in the Management and Prevention of Osteoarthritis |
Q38047227 | Nutraceuticals in the management of osteoarthritis : a critical review |
Q34636799 | Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities |
Q34059484 | Quantitation of glucosamine sulfate in plasma by HPLC-MS/MS after administration of powder for oral solution formulation. |
Q35632646 | Synthesis and characterization of a new Peptide prodrug of glucosamine with enhanced gut permeability |
Q34369140 | The effects of three-month oral supplementation with a nutraceutical and exercise on the locomotor pattern of aged horses |
Search more.